Inspira™ Technologies OXY B.H.N. Ltd., a medical technology firm, has announced the initiation of production for its medical device, the INSPIRA ART100.

The INSPIRA ART100 device is undergoing contract manufacturing by a technology company specializing in high-technology electronic assembly solutions for various industries, including medical, aerospace and aviation, communications, and defense. This manufacturing partner has initiated the production and assembly process for the first batch of INSPIRA ART100 devices.

These initial units are slated for deployment across several sites, pending regulatory clearance from the US Food and Drug Administration (FDA). 

Inspira™ Technologies is an innovative medical technology company in the respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology (INSPIRA ART), designed to rebalance patient oxygen saturation levels. This technology potentially allows patients to remain awake during treatment while reducing the need for highly invasive, risky, and costly mechanical ventilation systems that require intubation and medically induced coma. The Company's products have not yet been tested or used in humans and has not been approved by any regulatory entity.